{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:08:42Z","timestamp":1773288522442,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10067-024-07225-7","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:06:39Z","timestamp":1730970399000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based study"],"prefix":"10.1007","volume":"44","author":[{"given":"Oh Chan","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyeon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1189-7637","authenticated-orcid":false,"given":"Min-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"3","key":"7225_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34(3):585\u2013592","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"7225_CR2","first-page":"612","volume":"31","author":"C Papagoras","year":"2013","unstructured":"Papagoras C, Voulgari PV, Drosos AA (2013) Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 31(4):612\u2013620","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"7225_CR3","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1136\/annrheumdis-2018-213317","volume":"78","author":"S Mathieu","year":"2019","unstructured":"Mathieu S, Soubrier M (2019) Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis. Ann Rheum Dis 78(6):e57","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7225_CR4","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","volume":"75","author":"S Exarchou","year":"2016","unstructured":"Exarchou S, Lie E, Lindstr\u00f6m U, Askling J, Forsblad-d\u2019Elia H, Turesson C, Kristensen LE, Jacobsson LT (2016) Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis 75(8):1466\u20131472","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7225_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76(1):17\u201328","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7225_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/acr.20364","volume":"63","author":"S Mathieu","year":"2011","unstructured":"Mathieu S, Gossec L, Dougados M, Soubrier M (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63(4):557\u2013563","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"7225_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","volume":"11","author":"MT Nurmohamed","year":"2015","unstructured":"Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11(12):693\u2013704","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"7225_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, McInnes IB, Neurath MF (2021) Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med 385(7):628\u2013639","journal-title":"N Engl J Med"},{"issue":"10","key":"7225_CR9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS et al (2019) 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 71(10):1599\u20131613","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"7225_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7225_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/ard-2022-223298","volume":"82","author":"C Webers","year":"2023","unstructured":"Webers C, Ortolan A, Sepriano A, Falzon L, Baraliakos X, Landew\u00e9 RBM, Ramiro S, van der Heijde D, Nikiphorou E (2023) Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Ann Rheum Dis 82(1):130\u2013141","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7225_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4078\/jrd.2021.28.2.55","volume":"28","author":"RD Inman","year":"2021","unstructured":"Inman RD (2021) Axial spondyloarthritis: current advances, future challenges. J Rheum Dis 28(2):55\u201359","journal-title":"J Rheum Dis"},{"issue":"12","key":"7225_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3349\/ymj.2023.0151","volume":"64","author":"OC Kwon","year":"2023","unstructured":"Kwon OC, Park MC (2023) Drug retention rate and factors associated with discontinuation of interleukin-17 inhibitors in patients with axial spondyloarthritis. Yonsei Med J 64(12):697\u2013704","journal-title":"Yonsei Med J"},{"issue":"6917","key":"7225_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874","journal-title":"Nature"},{"issue":"3","key":"7225_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3132\/dvdr.2005.018","volume":"2","author":"AM Carter","year":"2005","unstructured":"Carter AM (2005) Inflammation, thrombosis and acute coronary syndromes. Diab Vasc Dis Res 2(3):113\u2013121","journal-title":"Diab Vasc Dis Res"},{"issue":"6","key":"7225_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrcardio.2009.57","volume":"6","author":"GE McKellar","year":"2009","unstructured":"McKellar GE, McCarey DW, Sattar N, McInnes IB (2009) Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 6(6):410\u2013417","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"7225_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","volume":"16","author":"M Robert","year":"2017","unstructured":"Robert M, Miossec P (2017) Effects of interleukin 17 on the cardiovascular system. Autoimmun Rev 16(9):984\u2013991","journal-title":"Autoimmun Rev"},{"issue":"4","key":"7225_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40744-020-00248-x","volume":"7","author":"P Karmacharya","year":"2020","unstructured":"Karmacharya P, Shahukhal R, Crowson CS, Murad MH, Davis JM 3rd, Shrestha P, Bekele D, Wright K, Chakradhar R, Dubreuil M (2020) Effects of therapies on cardiovascular events in ankylosing spondylitis: a systematic review and meta-analysis. Rheumatol Ther 7(4):993\u20131009","journal-title":"Rheumatol Ther"},{"issue":"5","key":"7225_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS (2017) Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 32(5):718\u2013728","journal-title":"J Korean Med Sci"},{"issue":"1","key":"7225_CR20","doi-asserted-by":"publisher","first-page":"11548","DOI":"10.1038\/s41598-022-15436-8","volume":"12","author":"OC Kwon","year":"2022","unstructured":"Kwon OC, Han K, Chun J, Kim R, Hong SW, Kim JH, Youn YH, Park H, Park MC (2022) Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study. Sci Rep 12(1):11548","journal-title":"Sci Rep"},{"issue":"10","key":"7225_CR21","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.117.309803","volume":"37","author":"MK Kim","year":"2017","unstructured":"Kim MK, Han K, Koh ES, Kim HS, Kwon HS, Park YM, Yoon KH, Lee SH (2017) Variability in total cholesterol is associated with the risk of end-stage renal disease: a nationwide population-based study. Arterioscler Thromb Vasc Biol 37(10):1963\u20131970","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"7225_CR22","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2017-00643","volume":"102","author":"YM Kang","year":"2017","unstructured":"Kang YM, Cho YK, Lee SE, Park JY, Lee WJ, Kim YJ, Jung CH (2017) Cardiovascular diseases and life expectancy in adults with type 2 diabetes: a Korean national sample cohort study. J Clin Endocrinol Metab 102(9):3443\u20133451","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7225_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.36628\/ijhf.2021.0023","volume":"3","author":"JJ Park","year":"2021","unstructured":"Park JJ, Lee CJ, Park SJ, Choi JO, Choi S, Park SM, Choi EY, Kim EJ, Yoo BS, Kang SM, Park MH, Lee J, Choi DJ (2021) Heart failure statistics in Korea, 2020: a report from the Korean Society of Heart Failure. Int J Heart Fail 3(4):224\u2013236","journal-title":"Int J Heart Fail"},{"issue":"17","key":"7225_CR24","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D H\u00fcrlimann","year":"2002","unstructured":"H\u00fcrlimann D, Forster A, Noll G et al (2002) Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106(17):2184\u20132187","journal-title":"Circulation"},{"issue":"12","key":"7225_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00296-006-0147-y","volume":"26","author":"W Bilsborough","year":"2006","unstructured":"Bilsborough W, Keen H, Taylor A, O\u2019Driscoll GJ, Arnolda L, Green DJ (2006) Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int 26(12):1125\u20131131","journal-title":"Rheumatol Int"},{"issue":"12","key":"7225_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrrheum.2009.219","volume":"5","author":"Z Szekanecz","year":"2009","unstructured":"Szekanecz Z, Kerekes G, Solt\u00e9sz P (2009) Vascular effects of biologic agents in RA and spondyloarthropathies. Nat Rev Rheumatol 5(12):677\u2013684","journal-title":"Nat Rev Rheumatol"},{"key":"7225_CR27","doi-asserted-by":"crossref","unstructured":"Chan SCW, Teo CK, Li PH, Lau KK, Lau CS, Chung HY (2021) Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs. Ther Adv Musculoskelet Dis 13:1759720x211032444","DOI":"10.1177\/1759720X211032444"},{"issue":"1","key":"7225_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13075-022-02836-4","volume":"24","author":"OC Kwon","year":"2022","unstructured":"Kwon OC, Park MC (2022) Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis. Arthritis Res Ther 24(1):141","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"7225_CR29","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74(3):480\u2013489","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"7225_CR30","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.3390\/jcm9103267","volume":"9","author":"F Rolski","year":"2020","unstructured":"Rolski F, B\u0142yszczuk P (2020) Complexity of TNF-\u03b1 signaling in heart disease. J Clin Med 9(10):3267","journal-title":"J Clin Med"},{"issue":"6","key":"7225_CR31","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1182\/blood-2005-03-1247","volume":"106","author":"P Pignatelli","year":"2005","unstructured":"Pignatelli P, De Biase L, Lenti L, Tocci G, Brunelli A, Cangemi R, Riondino S, Grego S, Volpe M, Violi F (2005) Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood 106(6):1992\u20131994","journal-title":"Blood"},{"issue":"1","key":"7225_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13075-016-1148-1","volume":"18","author":"S Hassan","year":"2016","unstructured":"Hassan S, Milman U, Feld J, Eder L, Lavi I, Cohen S, Zisman D (2016) Effects of anti-TNF-\u03b1 treatment on lipid profile in rheumatic diseases: an analytical cohort study. Arthritis Res Ther 18(1):261","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"7225_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4078\/jrd.2023.0040","volume":"31","author":"I Kwon","year":"2024","unstructured":"Kwon I, Choi N, Shin JH, Lee S, Nam B, Kim TH (2024) Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis. J Rheum Dis 31(1):41\u201348","journal-title":"J Rheum Dis"},{"issue":"1","key":"7225_CR34","doi-asserted-by":"publisher","first-page":"e000763","DOI":"10.1136\/rmdopen-2018-000763","volume":"5","author":"B Champs","year":"2019","unstructured":"Champs B, Degbo\u00e9 Y, Barnetche T, Cantagrel A, Ruyssen-Witrand A, Constantin A (2019) Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta-analysis of randomised controlled trials. RMD Open 5(1):e000763","journal-title":"RMD Open"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07225-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07225-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07225-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:54:58Z","timestamp":1739876098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07225-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7225"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07225-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}